Ultragenyx Pharmaceutical | RARE - Biaya Operasional





Biaya Operasional Perubahan Tanggal
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
BioCryst Pharmaceuticals USD -397.38M 517.17M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Immunic USD 23.33M 2.67M 2025-12
Insmed USD 606.26M 79.46M 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Kyowa Hakko Kirin JPY 94.9B 28B 2026-09
MacroGenics USD 42.87M 21.68M 2026-06
Moderna USD 1.18B 223M 2026-09
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09